Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2012, Article ID 607486, 13 pages
http://dx.doi.org/10.1155/2012/607486
Review Article

Myocardial Viability: What We Knew and What Is New

1The Department of Clinical Medicine, Weill Cornell Medical College, P.O. Box 24144, Doha, Qatar
2The Department of Cardiology, Hamad Medical Corporation, P.O. Box 3050, Doha, Qatar
3Clinical Research, Trauma Surgery Unit, Hamad General Hospital, P.O. Box 3050, Doha, Qatar

Received 11 April 2012; Revised 29 May 2012; Accepted 9 June 2012

Academic Editor: H. A. Katus

Copyright © 2012 Adel Shabana and Ayman El-Menyar. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W. Rosamond, K. Flegal, K. Furie et al., “Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee,” Circulation, vol. 117, pp. e25–e146, 2008. View at Publisher · View at Google Scholar
  2. R. O. Bonow, V. Dilsizian, A. Cuocolo, and S. L. Bacharach, “Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphyly with reinjection and PET imaging with 18F-fluorodeoxyglucose,” Circulation, vol. 83, no. 1, pp. 26–37, 1991. View at Google Scholar · View at Scopus
  3. G. A. Diamond, J. S. Forrester, and P. L. DeLuz, “Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation,” American Heart Journal, vol. 95, no. 2, pp. 204–209, 1978. View at Google Scholar · View at Scopus
  4. S. H. Rahimtoola, “A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina,” Circulation, vol. 72, no. 6, pp. V123–V135, 1985. View at Google Scholar · View at Scopus
  5. E. Braunwald and J. D. Rutherford, “Reversible ischemic left ventricular dysfunction: evidence for the ‘hibernating myocardium’,” Journal of the American College of Cardiology, vol. 8, no. 6, pp. 1467–1470, 1986. View at Google Scholar · View at Scopus
  6. S. R. Redwood, R. Ferrari, and M. S. Marber, “Myocardial hibernation and stunning: from physiological principles to clinical practice,” Heart, vol. 80, no. 3, pp. 218–222, 1998. View at Google Scholar · View at Scopus
  7. B. Page, R. Young, V. Iyer et al., “Persistent regional downregulation in mitochondrial enzymes and upregulation of stress proteins in swine with chronic hibernating myocardium,” Circulation Research, vol. 102, no. 1, pp. 103–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Depre and S. F. Vatner, “Cardioprotection in stunned and hibernating myocardium,” Heart Failure Reviews, vol. 12, no. 3-4, pp. 307–317, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Depre, S. J. Kim, A. S. John et al., “Program of cell survival underlying human and experimental hibernating myocardium,” Circulation Research, vol. 95, no. 4, pp. 433–440, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Slezak, N. Tribulova, L. Okruhlicova et al., “Hibernating myocardium: pathophysiology, diagnosis, and treatment,” Canadian Journal of Physiology and Pharmacology, vol. 87, no. 4, pp. 252–265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Ross, “Myocardial persusion-contraction matching. Implications for coronary heart disease and hibernation,” Circulation, vol. 83, no. 3, pp. 1076–1083, 1991. View at Google Scholar · View at Scopus
  12. R. F. Kelly, W. Sluiter, and E. O. McFalls, “Hibernating myocardium: Is the program to survive a pathway to failure?” Circulation Research, vol. 102, no. 1, pp. 3–5, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. G. R. Heyndrickx, R. W. Millard, R. J. McRitchie, P. R. Maroko, and S. F. Vatner, “Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs,” Journal of Clinical Investigation, vol. 56, no. 4, pp. 978–985, 1975. View at Google Scholar · View at Scopus
  14. L. Piérard and E. Picano, “Myocardial viability,” in Stress Echocardiography, E. Picano, Ed., pp. 273–294, Springer, Berlin, Germany, 2009. View at Google Scholar
  15. Y. T. Shen and S. F. Vatner, “Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs: hibernation versus stunning?” Circulation Research, vol. 76, no. 3, pp. 479–488, 1995. View at Google Scholar · View at Scopus
  16. A. Maes, W. Flameng, J. Nuyts et al., “Histological alterations in chronically hypoperfused myocardium: correlation with PET findings,” Circulation, vol. 90, no. 2, pp. 735–745, 1994. View at Google Scholar · View at Scopus
  17. J. L. J. Vanoverschelde, W. Wijns, C. Depre et al., “Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium,” Circulation, vol. 87, no. 5, pp. 1513–1523, 1993. View at Google Scholar · View at Scopus
  18. D. C. Homans, D. D. Laxson, E. Sublett, P. Lindstrom, and R. J. Bache, “Cumulative deterioration of myocardial function after repeated episodes of exercise-induced ischemia,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 256, no. 5, pp. H1462–H1471, 1989. View at Google Scholar · View at Scopus
  19. M. Borgers, F. Thoné, L. Wouters, J. Ausma, B. Shivalkar, and W. Flameng, “Structural correlates of regional myocardial dysfunction in patients with critical coronary artery stenosis: chronic hibernation?” Cardiovascular Pathology, vol. 2, no. 4, pp. 237–245, 1993. View at Google Scholar · View at Scopus
  20. E. R. Schwarz, J. Schaper, J. V. vom Dahl et al., “Myocyte degeneration and cell death in hibernating human myocardium,” Journal of the American College of Cardiology, vol. 27, no. 7, pp. 1577–1585, 1996. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Bito, J. van der Velden, P. Claus et al., “Reduced force generating capacity in myocytes from chronically ischemic, hibernating myocardium,” Circulation Research, vol. 100, no. 2, pp. 229–237, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Elsässer, K. D. Müller, W. Skwara, C. Bode, W. Kübler, and A. M. Vogt, “Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death,” Journal of the American College of Cardiology, vol. 39, no. 7, pp. 1189–1198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. A. F. L. Schinkel, R. Valkema, M. L. Geleijnse, E. J. Sijbrands, and D. Poldermans, “Single-photon emission computed tomography for assessment of myocardial viability,” EuroIntervention, vol. 6, supplement G, pp. G115–G122, 2010. View at Google Scholar · View at Scopus
  24. B. Caner and G. A. Beller, “Are technetium-99m-labeled myocardial perfusion agents adequate for detection of myocardial viability?” Clinical Cardiology, vol. 21, no. 4, pp. 235–242, 1998. View at Google Scholar · View at Scopus
  25. A. F. L. Schinkel, J. J. Bax, E. Boersma et al., “Assessment of residual myocardial viability in regions with chronic electrocardiographic Q-wave infarction,” American Heart Journal, vol. 144, no. 5, pp. 865–869, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. M. K. Das, B. Khan, S. Jacob, A. Kumar, and J. Mahenthiran, “Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease,” Circulation, vol. 113, no. 21, pp. 2495–2501, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. D. D. Wang, D. M. Buerkel, J. R. Corbett, and H. S. Gurm, “Fragmented QRS complex has poor sensitivity in detecting myocardial scar,” Annals of Noninvasive Electrocardiology, vol. 15, no. 4, pp. 308–314, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. V. Bodí, J. Sanchis, A. Llàcer, L. Insa, F. J. Chorro, and V. López-Merino, “ST-segment elevation on Q leads at rest and during exercise: relation with myocardial viability and left ventricular remodeling within the first 6 months after infarction,” American Heart Journal, vol. 137, no. 6, pp. 1107–1015, 1999. View at Google Scholar · View at Scopus
  29. L. A. Piérard, P. Lancellotti, and H. E. Kulbertus, “ST-segment elevation during dobutamine stress testing predicts functional recovery after acute myocardial infarction,” American Heart Journal, vol. 137, no. 3, pp. 500–511, 1999. View at Google Scholar · View at Scopus
  30. A. Margonato, S. L. Chierchia, R. G. Xuereb et al., “Specificity and sensitivity of exercise-induced ST segment elevation for detection of residual viability: comparison with fluorodeoxyglucose and positron emission tomography,” Journal of the American College of Cardiology, vol. 25, no. 5, pp. 1032–1038, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Nakano, J. D. Lee, H. Shimizu et al., “Reciprocal ST-segment depression associated with exercise-induced ST- segment elevation indicates residual viability after myocardial infarction,” Journal of the American College of Cardiology, vol. 33, no. 3, pp. 620–626, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. C. A. Schneider, A. K. Helmig, F. M. Baer, M. Horst, E. Erdmann, and U. Sechtem, “Significance of exercise-induced ST-segment elevation and T-wave pseudonormalization for improvement of function in healed Q-wave myocardial infarction,” American Journal of Cardiology, vol. 82, no. 2, pp. 148–153, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. C. A. Schneider, E. Voth, F. M. Baer, M. Horst, R. Wagner, and U. Sechtem, “QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction,” Circulation, vol. 96, no. 11, pp. 3913–3920, 1997. View at Google Scholar · View at Scopus
  34. V. S. Banka, M. M. Bodenheimer, R. Shah, and R. H. Helfant, “Intervention ventriculography. Comparative value of nitroglycerin, post extrasystolic potentiation and nitroglycerin plus post extrasystolic potentiation,” Circulation, vol. 53, no. 4, pp. 632–637, 1976. View at Google Scholar · View at Scopus
  35. L. D. Vecchia, T. Storti, C. Cogliati et al., “Comparison of low-dose dobutamine ventriculography with low-dose dobutamine echocardiography for predicting regional improvement in left ventricular function after coronary artery bypass grafting,” American Journal of Cardiology, vol. 86, no. 4, pp. 371–374, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. T. H. Tajouri and P. Chareonthaitawee, “Myocardial viability imaging and revascularization in chronic ischemic left ventricular systolic dysfunction,” Expert Review of Cardiovascular Therapy, vol. 8, no. 1, pp. 55–63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. A. F. L. Schinkel, J. J. Bax, and D. Poldermans, “Clinical assessment of myocardial hibernation,” Heart, vol. 91, no. 1, pp. 111–117, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. S. R. Underwood, J. J. Bax, J. vom Dahl et al., “Imaging techniques for the assessment of myocardial hibernation: report of a Study Group of the European Society of Cardiology,” European Heart Journal, vol. 25, no. 10, pp. 815–836, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. V. Dilsizian, J. Shirani, Y. Lee et al., “Specific binding of [18F] fluorobenzoyl-lisinopril to angiotensin converting enzyme in human heart tissue of ischemic cardiomyopathy,” Circulation, vol. 104, p. II-694, 2001. View at Google Scholar
  40. J. A. Arrighi and V. Dilsizian, “Assessment of myocardial viability by radionuclide and echocardiographic techniques: Is it simply a sensitivity and specificity issue?” Current Opinion in Cardiology, vol. 21, no. 5, pp. 450–456, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. J. W. Weinsaft, I. Klem, and R. M. Judd, “MRI for the assessment of myocardial viability,” Magnetic Resonance Imaging Clinics of North America, vol. 15, no. 4, pp. 505–525, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. G. J. Kauffman, T. S. Boyne, D. D. Watson, W. H. Smith, and G. A. Beller, “Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 27, no. 7, pp. 1592–1597, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Spadafora, P. Varrella, W. Acampa et al., “Direct imaging of viable myocardium by gated SPECT in patients with ischaemic left ventricular dysfunction,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 9, pp. 1730–1735, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Bisi, R. Sciagra, G. M. Santoro, and P. F. Fazzini, “Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories,” Journal of the American College of Cardiology, vol. 24, no. 5, pp. 1282–1289, 1994. View at Google Scholar · View at Scopus
  45. M. Ciavolella, C. Greco, R. Tavolaro, G. Tanzilli, F. Scopinaro, and P. P. Campa, “Acute oral trimetazidine administration increases resting technetium 99m sestamibi uptake in hibernating myocardium,” Journal of Nuclear Cardiology, vol. 5, no. 2, pp. 128–133, 1998. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Feola, A. Biggi, A. Francini et al., “Placebo or trimetazidine 99mTc tetrofosmin myocardial SPECT and low-dose dobutamine echocardiography in hibernating myocardium,” Archives of Medical Research, vol. 37, no. 1, pp. 117–122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Feola, A. Biggi, A. Francini et al., “The acute administration of trimetazidine modified myocardial perfusion and left ventricular function in 31 patients with ischaemic ventricular dysfunction,” The International Journal of Cardiovascular Imaging, vol. 20, no. 5, pp. 315–320, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Mori, M. Hayakawa, K. Hattori et al., “Exercise β-methyl iodophenyl pentadecanoic acid (BMIPP) and resting thalium delayed single photon emission computed tomography (SPECT) in the assessment of ischemia and viability,” Japanese Circulation Journal, vol. 60, no. 1, pp. 17–26, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. M. M. Goodman, K. H. Neff, K. R. Ambrose, and F. F. Knapp, “Effect of 3-methyl-branching on the myocardial retention of radioiodinated 19-iodo-18-nonadecenoic acid analogues,” International Journal of Radiation Applications and Instrumentation, vol. 16, no. 8, pp. 813–819, 1989. View at Google Scholar · View at Scopus
  50. P. R. Franken, F. de Geeter, P. Dendale, D. Demoor, P. Block, and A. Bossuyt, “Abnormal free fatty acid uptake in subacute myocardial infarction after coronary thrombolysis: correlation with wall motion and inotropic reserve,” Journal of Nuclear Medicine, vol. 35, no. 11, pp. 1758–1765, 1994. View at Google Scholar · View at Scopus
  51. N. Hattori and M. Schwaiger, “Metaiodobenzyl-guanidine scintigraphy of the heart: What we have learned clinically?” in European Journal of Nuclear Medicine and Molecular, vol. 27, no. 1, pp. 1–6, 2000. View at Publisher · View at Google Scholar
  52. D. Agostini, I. Carrio, and H. J. Verberne, “How to use myocardial 123I-MIBG scintigraphy in chronic heart failure,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 4, pp. 555–559, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. M. J. Knuuti, M. Saraste, P. Nuutila et al., “Myocardial viability: fluorine-18-deoxyglcose positron emission tomography in prediction of wall motion recovery after revascularization,” American Heart Journal, vol. 127, no. 4, pp. 785–796, 1994. View at Publisher · View at Google Scholar · View at Scopus
  54. H. P. Stoll, N. Hellwig, C. Alexander, C. Ozbek, H. Schieffer, and E. Oberhausen, “Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography,” European Journal of Nuclear Medicine, vol. 21, no. 10, pp. 1085–1093, 1994. View at Google Scholar · View at Scopus
  55. B. Nowak, M. Zimny, E. R. Schwarz et al., “Diagnosis of myocardial viability by dual-head coincidence gamma camera fluorine-18 fluorodeoxyglucose positron emission tomography with and without non-uniform attenuation correction,” European Journal of Nuclear Medicine, vol. 27, no. 10, pp. 1501–1508, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. A. J. Einstein, K. W. Moser, R. C. Thompson, M. D. Cerqueira, and M. J. Henzlova, “Radiation dose to patients from cardiac diagnostic imaging,” Circulation, vol. 116, no. 11, pp. 1290–1305, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Perrone-Filardi, L. Pace, M. Prastaro et al., “Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularization in patients with coronary artery disease,” Circulation, vol. 91, no. 10, pp. 2556–2565, 1995. View at Google Scholar · View at Scopus
  58. T. Haque, T. Furukawa, M. Takahashi, and M. Kinoshita, “Identification of hibernating myocardium by dobutamine stress echocardiography: comparison with thallium-201 reinjection imaging,” American Heart Journal, vol. 130, no. 3, pp. 553–563, 1995. View at Google Scholar · View at Scopus
  59. D. S. McLean, A. V. Anadiotis, and S. Lerakis, “Role of echocardiography in the assessment of myocardial viability,” American Journal of the Medical Sciences, vol. 337, no. 5, pp. 349–354, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. W. F. Armstrong and T. Ryan, “Stress echocardiography from 1979 to present,” Journal of the American Society of Echocardiography, vol. 21, no. 1, pp. 22–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Janardhanan, J. C. C. Moon, D. J. Pennell, and R. Senior, “Myocardial contrast echocardiography accurately reflects transmurality of myocardial necrosis and predicts contractile reserve after acute myocardial infarction,” American Heart Journal, vol. 149, no. 2, pp. 355–362, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. S. Shimoni, N. G. Frangogiannis, C. J. Aggeli et al., “Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy,” Circulation, vol. 107, no. 4, pp. 538–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Korosoglou, A. Hansen, J. Hoffend et al., “Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodeoxyglucose-18 positron emission tomography and dobutamine stress echocardiography,” American Journal of Cardiology, vol. 94, no. 5, pp. 570–576, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. G. Dwivedi, R. Janardhanan, S. A. Hayat, T. K. Lim, and R. Senior, “Comparison between myocardial contrast echocardiography and 99mtechnetium sestamibi single photon emission computed tomography determined myocardial viability in predicting hard hardiac events following acute myocardial infarction,” American Journal of Cardiology, vol. 104, no. 9, pp. 1184–1188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Tousek, M. Penicka, J. Tintera, H. Linkova, and P. Gregor, “Identification of hibernating myocardium with myocardial contrast echocardiography. Comparison with late gadolinium-enhanced magnetic resonance,” International Journal of Cardiology, vol. 128, no. 1, pp. 117–120, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. L. Hanekom, C. Jenkins, L. Jeffries et al., “Incremental value of strain rate analysis as an adjunct to wall-motion scoring for assessment of myocardial viability by dobutamine echocardiography: a follow-up study after revascularization,” Circulation, vol. 112, no. 25, pp. 3892–3900, 2005. View at Publisher · View at Google Scholar · View at Scopus
  67. R. Hoffmann, E. Altiok, B. Nowak et al., “Strain rate measurement by Doppler echocardiography allows improved assessment of myocardial viability in patients with depressed left ventricular function,” Journal of the American College of Cardiology, vol. 39, no. 3, pp. 443–449, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Bountioukos, A. F. L. Schinkel, J. J. Bax et al., “Pulsed-wave tissue Doppler quantification of systolic and diastolic function of viable and nonviable myocardium in patients with ischemic cardiomyopathy,” American Heart Journal, vol. 148, no. 6, pp. 1079–1084, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. H. S. Yang, S. J. Kang, J. K. Song et al., “Diagnosis of viable myocardium using velocity data of doppler myocardial imaging: comparison with positron emission tomography,” Journal of the American Society of Echocardiography, vol. 17, no. 9, pp. 933–940, 2004. View at Publisher · View at Google Scholar · View at Scopus
  70. R. Rambaldi, D. Poldermans, J. J. Bax et al., “Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction,” European Heart Journal, vol. 21, no. 13, pp. 1091–1098, 2000. View at Publisher · View at Google Scholar · View at Scopus
  71. N. L. Greenberg, M. S. Firstenberg, P. L. Castro et al., “Doppler-derived myocardial systolic strain rate is a strong index of left ventricular contractility,” Circulation, vol. 105, no. 1, pp. 99–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. M. Bountioukos, A. F. L. Schinkel, J. J. Bax et al., “Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium,” Heart, vol. 90, no. 5, pp. 506–510, 2004. View at Google Scholar · View at Scopus
  73. J. Chan, L. Hanekom, C. Wong, R. Leano, G. Y. Cho, and T. H. Marwick, “Differentiation of subendocardial and transmural infarction using two-dimensional strain rate imaging to assess short-axis and long-axis myocardial function,” Journal of the American College of Cardiology, vol. 48, no. 10, pp. 2026–2033, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. H. Fujimoto, H. Honma, T. Ohno, K. Mizuno, and S. Kumita, “Longitudinal Doppler strain measurement for assessment of damaged and/or hibernating myocardium by dobutamine stress echocardiography in patients with old myocardial infarction,” Journal of Cardiology, vol. 55, no. 3, pp. 309–316, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. R. Hoffmann, E. Altiok, B. Nowak et al., “Strain rate analysis allows detection of differences in diastolic function between viable and nonviable myocardial segments,” Journal of the American Society of Echocardiography, vol. 18, no. 4, pp. 330–335, 2005. View at Publisher · View at Google Scholar · View at Scopus
  76. R. Hoffmann, “Tissue Doppler and innovative myocardial-deformation imaging techniques for assessment of myocardial viability,” Current Opinion in Cardiology, vol. 21, no. 5, pp. 438–442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Urheim, T. Edvardsen, H. Torp, B. Angelsen, and O. A. Smiseth, “Myocardial strain by Doppler echocardiography: validation of a new method to quantify regional myocardial function,” Circulation, vol. 102, no. 10, pp. 1158–1164, 2000. View at Google Scholar · View at Scopus
  78. K. Iwakura, A. Okamura, Y. Koyama et al., “Automated assessment of myocardial viability after acute myocardial infarction by global longitudinal peak strain on low-dose dobutamine stress echocardiography,” Circulation Journal, vol. 74, no. 10, pp. 2158–2165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Ahmad, X. Tianrong, M. McCulloch, G. Abreo, and M. Runge, “Real-time three-dimensional dobutamine stress echocardiography in assessment of ischemia: comparison with two-dimensional dobutamine stress echocardiography,” Journal of the American College of Cardiology, vol. 37, no. 5, pp. 1303–1309, 2001. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Pasquet, A. M. D'Hondt, J. A. Melin, and J. L. J. Vanoverschelde, “Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in chronic left ventricular ischemic dysfunction,” American Journal of Cardiology, vol. 81, no. 1, pp. 68–74, 1998. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Poon, V. Fuster, and Z. Fayad, “Cardiac magnetic resonance imaging: a “one-stop-shop” evaluation of myocardial dysfunction,” Current Opinion in Cardiology, vol. 17, no. 6, pp. 663–670, 2002. View at Publisher · View at Google Scholar · View at Scopus
  82. H. Mahrholdt, I. Klem, and U. Sechtem, “Cardiovascular MRI for detection of myocardial viability and ischaemia,” Heart, vol. 93, no. 1, pp. 122–129, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. H. M. J. Siebelink and H. J. Lamb, “Magnetic resonance imaging for myocardial viability,” EuroIntervention, vol. 6, supplement G, pp. G107–G114, 2010. View at Google Scholar · View at Scopus
  84. F. M. Baer, P. Theissen, C. A. Schneider et al., “Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization,” Journal of the American College of Cardiology, vol. 31, no. 5, pp. 1040–1048, 1998. View at Publisher · View at Google Scholar · View at Scopus
  85. O. P. Simonetti, R. J. Kim, D. S. Fieno et al., “An improved MR imaging technique for the visualization of myocardial infarction,” Radiology, vol. 218, no. 1, pp. 215–223, 2001. View at Google Scholar · View at Scopus
  86. K. M. Choi, R. J. Kim, G. Gubernikoff, J. D. Vargas, M. Parker, and R. M. Judd, “Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function,” Circulation, vol. 104, no. 10, pp. 1101–1107, 2001. View at Google Scholar · View at Scopus
  87. G. Tarantini, R. Razzolini, L. Cacciavillani et al., “Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty,” American Journal of Cardiology, vol. 98, no. 8, pp. 1033–1040, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. R. J. Kim, E. Wu, A. Rafael et al., “The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction,” New England Journal of Medicine, vol. 343, no. 20, pp. 1445–1453, 2000. View at Publisher · View at Google Scholar · View at Scopus
  89. J. B. Selvanayagam, A. Kardos, J. M. Francis et al., “Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization,” Circulation, vol. 110, no. 12, pp. 1535–1541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. Y. Ichikawa, H. Sakuma, N. Suzawa et al., “Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction: improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium,” Journal of the American College of Cardiology, vol. 45, no. 6, pp. 901–909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  91. C. Klein, S. G. Nekolla, F. M. Bengel et al., “Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging comparison with positron emission tomography,” Circulation, vol. 105, no. 2, pp. 162–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  92. D. R. Tomlinson, H. Becher, and J. B. Selvanayagam, “Assessment of myocardial viability: comparison of echocardiography versus cardiac magnetic resonance Imaging in the current era,” Heart Lung and Circulation, vol. 17, no. 3, pp. 173–185, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Wagner, H. Mahrholdt, T. A. Holly et al., “Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study,” The Lancet, vol. 361, no. 9355, pp. 374–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  94. E. Nagel and A. Schuster, “Myocardial viability: dead or alive is not the question!,” JACC: Cardiovascular Imaging, vol. 5, no. 5, pp. 509–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. M. F. di Carli and R. Hachamovitch, “New technology for noninvasive evaluation of coronary artery disease,” Circulation, vol. 115, no. 11, pp. 1464–1480, 2007. View at Publisher · View at Google Scholar · View at Scopus
  96. A. H. Mahnken, R. Koos, M. Katoh et al., “Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging,” Journal of the American College of Cardiology, vol. 45, no. 12, pp. 2042–2047, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. K. R. Chiou, C. P. Liu, N. J. Peng et al., “Identification and viability assessment of infarcted myocardium with late enhancement multidetector computed tomography: comparison with thallium single photon emission computed tomography and echocardiography,” American Heart Journal, vol. 155, no. 4, pp. 738–745, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. S. A. Ben-Haim, D. Osadchy, I. Schuster, L. Gepstein, G. Hayam, and M. E. Josephson, “Nonfluoroscopic, in vivo navigation and mapping technology,” Nature Medicine, vol. 2, no. 12, pp. 1393–1395, 1996. View at Publisher · View at Google Scholar · View at Scopus
  99. R. Kornowski, M. K. Hong, and M. B. Leon, “Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability,” Circulation, vol. 98, no. 18, pp. 1837–1841, 1998. View at Google Scholar · View at Scopus
  100. R. Kornowski, M. K. Hong, L. Gepstein et al., “Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium,” Circulation, vol. 98, no. 11, pp. 1116–1124, 1998. View at Google Scholar · View at Scopus
  101. K. C. Koch, J. V. Dahl, M. Wenderdel et al., “Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization,” Journal of the American College of Cardiology, vol. 38, no. 1, pp. 91–98, 2001. View at Publisher · View at Google Scholar · View at Scopus
  102. H. E. Bøtker, J. F. Lassen, F. Hermansen et al., “Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy,” Circulation, vol. 103, no. 12, pp. 1631–1637, 2001. View at Google Scholar · View at Scopus
  103. A. F. L. Schinkel, J. J. Bax, D. Poldermans, A. Elhendy, R. Ferrari, and S. H. Rahimtoola, “Hibernating myocardium: diagnosis and patient outcomes,” Current Problems in Cardiology, vol. 32, no. 7, pp. 375–410, 2007. View at Publisher · View at Google Scholar · View at Scopus
  104. J. J. Bax, D. Poldermans, A. Elhendy, E. Boersma, and S. H. Rahimtoola, “Sensitivity, specificity, and predictive accuracies of various noninvasive techniques for detecting hibernating myocardium,” Current Problems in Cardiology, vol. 26, no. 2, pp. 141–186, 2001. View at Google Scholar · View at Scopus
  105. S. S. Yao and F. A. Chaudhry, “Assessment of myocardial viability: an effective gatekeeper for coronary revascularization?” Future Cardiology, vol. 4, no. 5, pp. 443–447, 2008. View at Publisher · View at Google Scholar · View at Scopus
  106. J. G. F. Cleland, D. J. Pennell, S. G. Ray et al., “Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial,” The Lancet, vol. 362, no. 9377, pp. 14–21, 2003. View at Publisher · View at Google Scholar · View at Scopus
  107. P. G. Camici, S. K. Prasad, and O. E. Rimoldi, “Stunning, hibernation, and assessment of myocardial viability,” Circulation, vol. 117, no. 1, pp. 103–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  108. J. E. Udelson, C. A. Pearte, C. D. Kimmelstiel et al., “The occluded artery trial (OAT) viability ancillary study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone,” American Heart Journal, vol. 161, no. 3, pp. 611–621, 2011. View at Publisher · View at Google Scholar · View at Scopus
  109. C. G. Cigarroa, C. R. deFilippi, M. E. Brickner, L. G. Alvarez, M. A. Wait, and P. A. Grayburn, “Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization,” Circulation, vol. 88, no. 2, pp. 430–436, 1993. View at Google Scholar · View at Scopus
  110. T. H. Marwick, “Stress echocardiography,” Heart, vol. 89, no. 1, pp. 113–118, 2003. View at Google Scholar · View at Scopus
  111. K. C. Allman, L. J. Shaw, R. Hachamovitch, and J. E. Udelson, “Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis,” Journal of the American College of Cardiology, vol. 39, no. 7, pp. 1151–1158, 2002. View at Publisher · View at Google Scholar · View at Scopus
  112. A. T. L. Ong and P. W. Serruys, “Complete revascularization: coronary artery bypass graft surgery versus percutaneous coronary intervention,” Circulation, vol. 114, no. 3, pp. 249–255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. R. Bonow, G. Maurer, K. Lee et al., “Myocardial viability and survival in ischemic left ventricular dysfunction,” The New England Journal of Medicine, vol. 364, pp. 1617–1625, 2011. View at Publisher · View at Google Scholar
  114. A. Desideri, L. Cortigiani, A. I. Christen et al., “The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction,” Journal of the American College of Cardiology, vol. 46, no. 7, pp. 1264–1269, 2005. View at Publisher · View at Google Scholar · View at Scopus
  115. M. Pitt, D. Dutka, D. Pagano, P. Camici, and R. Bonser, “The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function,” European Heart Journal, vol. 25, no. 6, pp. 500–507, 2004. View at Publisher · View at Google Scholar · View at Scopus
  116. K. G. Tarakji, R. Brunken, P. M. McCarthy et al., “Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction,” Circulation, vol. 113, no. 2, pp. 230–237, 2006. View at Publisher · View at Google Scholar · View at Scopus
  117. J. G. F. Cleland, M. Calvert, N. Freemantle et al., “The heart failure revascularisation trial (HEART),” European Journal of Heart Failure, vol. 13, no. 2, pp. 227–233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  118. B. L. Gerber, M. F. Rousseau, S. A. Ahn et al., “Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy,” Journal of the American College of Cardiology, vol. 59, no. 9, pp. 825–835, 2012. View at Publisher · View at Google Scholar · View at Scopus